Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Combination Therapy
Sort By
Newest First
Sign in
1 / 1
1 / 1
Approval
Triple Combination Treatments for Multiple Myeloma Approved in Europe
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M05-19-NI-027
May 29, 2019
Approval
European Commission Approved Tecentriq/Avastin Combination Therapy for Lung Cancer
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M03-19-NI-018-2902
Mar 12, 2019
Combination Treatment
MedImmune, NeoTX to Study Combination Treatment
Emilie Branch
Pharma's Almanac
PAO-M02-19-NI-016
Feb 19, 2019
Drug Development
Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the U.S.
Mylan
PR-M03-18-NI-023
Mar 07, 2018
Breakthrough Therapy
Eisai and Merck Receive Breakthrough Therapy Designation from FDA for LENVIMA® (lenvatinib mesylate) and KEYTRUDA® (pembrolizumab) as Combination Therapy
Eisai
PR-M01-18-NI-032
Jan 12, 2018
Combination Therapy
Researchers at the University of Colorado Develop New Combination Hepatitis C Treatment
Emilie Branch
Pharma's Almanac
PAO-M08-17-NI-035
Aug 25, 2017
Oncology
Quadruple Myeloma Combination Treatment Study Begins
Guy Tiene
Nice Insight
PAO-M08-17-NI-027
Aug 17, 2017
Drug Development
New Partnership Targets Colorectal Cancer with Combination Therapy, Including Avelumab
Guy Tiene
Nice Insight
PAO-M06-17-NI-020
Jun 29, 2017
